Latest filing published 18 Jun 2025 for Elevation Oncology, Inc..
Insider track record
No signal scores available.
Joseph J. Ferra Jr.: trading record in brief
Joseph J. Ferra Jr. discloses dealings in 2 companies, chiefly Elevation Oncology, Inc. and Syros Pharmaceuticals, Inc. In total, 31 filings cover trades dated from 12 February 2019 to 16 June 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 18 June 2025 with a share grant (€1,544) in Elevation Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joseph J. Ferra Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,560 sharesCommon StockSEC:0001415889-25-017667:0
- 6,250 sharesCommon StockSEC:0001415889-25-013611:0
- 12,562 sharesCommon StockSEC:0001415889-25-008380:0
- 25,000 sharesCommon StockSEC:0001415889-25-004589:0
- 12,563 sharesCommon StockSEC:0001415889-24-029728:0
- 12,562 sharesCommon StockSEC:0001415889-24-023607:0
- 12,562 sharesCommon StockSEC:0001415889-24-017385:0
- 12,562 sharesCommon StockSEC:0001415889-24-008492:0
- 12,563 sharesCommon StockSEC:0001415889-23-016727:0
- 12,562 sharesCommon StockSEC:0001415889-23-013411:0
- 12,563 sharesCommon StockSEC:0001415889-23-010088:0
- 12,563 sharesCommon StockSEC:0001415889-23-005216:0
- 50,249 sharesCommon StockSEC:0001415889-22-012784:0
13 of 13 declarations
